cIAP1/2 inhibition synergizes with TNF inhibition in autoimmunity by down-regulating IL-17A and inducing Tregs by Kawalkowska, JZ, Ogbechi, J, Venables, PJ, Williams, RO

IDO and kunurenine metabolites in peripheral and CNS disorders by Huang, Y-S, Ogbechi, J, Clanchy, FI, Williams, RO, Stone, TW

IDO activation, inflammation and musculoskeletal disease by Ogbechi, J, Clanchy, F, Huang, Y, Topping, L, Stone, T, Williams, R

Induction of IDO1 and kynurenine by serine proteases subtilisin, prostate specific antigen, CD26 and HtrA: a new form of immunosuppression? by Clanchy, FIL, Huang, Y-S, Ogbechi, J, Darlington, LG, Williams, RO, Stone, TW

TNF receptor 2 signaling prevents DNA methylation at the Foxp3 promoter and prevents pathogenic conversion of regulatory T cells. by Tseng, W, Huang, Y, Clanchy, F, McNamee, K, Perocheau, D, Ogbechi, J, Luo, S, Feldmann, M, McCann, F, Williams, R

TNF Receptor 2 Signaling Prevents DNA Methylation at the Foxp3 Promoter and Prevents Pathogenic Conversion of Regulatory T Cells by Tseng, W-Y, Huang, Y-S, Clanchy, F, McNamee, K, Perocheau, D, Ogbechi, J, Luo, S-F, Feldmann, M, McCann, F, Williams, RO

The extracellular heparan sulfatase SULF2 limits myeloid IFNβ signaling and Th17 responses in inflammatory arthritis by Swart, M, Redpath, AN, Ogbechi, J, Cardenas, R, Topping, L, Compeer, EB, Goddard, M, Chanalaris, A, Williams, R, Brewer, DS, Smart, N, Monaco, C, Troeberg, L

Pharmacological modulation of T cell immunity results in long-term remission of autoimmune arthritis by Huang, Y-S, Tseng, W-Y, Clanchy, FIL, Topping, ML, Ogbechi, J, McNamee, K, Perocheau, D, Chiang, N-Y, Ericsson, P, Sundstedt, A, Xue, Z-T, Salford, LG, Sjögren, H-O, Stone, TW, Lin, H-H, Luo, S-F, Williams, RO